September 3, 2024Open Access

Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

Key Points

Key points are not available for this paper at this time.

Abstract

Data on the efficacy and safety of anti PD-1 antibodies in children and adolescents (CA) with melanoma are lacking. The aim of this study was to determine outcomes of CA melanoma patients receiving anti PD-1 antibodies.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Mario Mandalà

Andrea Ferrari

Ines B. Brecht

Journals

European Journal of Cancer

Actions

Institutions

New York University

Karolinska Institutet

The University of Sydney

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study